02/14/2020
3:20 PM | Audentes Therapeutics (Subject)
GREAT POINT PARTNERS LLC (Filed by)
| Form SC 13G/A
| |
01/27/2020
8:38 AM | Audentes Therapeutics (Filer)
| Form 15-12B
| |
01/20/2020
11:15 PM | Audentes Therapeutics (Filer)
| Form EFFECT
| |
01/20/2020
11:15 PM | Audentes Therapeutics (Filer)
| Form EFFECT
| |
01/15/2020
12:38 PM | Audentes Therapeutics (Issuer)
Soloway Thomas P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2020
12:37 PM | Audentes Therapeutics (Issuer)
Smith Julie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2020
12:36 PM | Audentes Therapeutics (Issuer)
Schuetz Thomas J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2020
12:35 PM | Audentes Therapeutics (Issuer)
Patterson Matthew R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2020
12:34 PM | Audentes Therapeutics (Issuer)
Mosbrooker Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2020
12:33 PM | Audentes Therapeutics (Issuer)
Morrison Scott W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
01/15/2020
12:32 PM | Audentes Therapeutics (Issuer)
Meltz Mark A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2020
12:31 PM | Audentes Therapeutics (Issuer)
LANGE LOUIS G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2020
12:30 PM | Audentes Therapeutics (Issuer)
Jarrett Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2020
12:29 PM | Audentes Therapeutics (Issuer)
Holles Natalie C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2020
12:27 PM | Audentes Therapeutics (Issuer)
Goldberg Mark Alan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2020
12:26 PM | Audentes Therapeutics (Issuer)
Conner Edward R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2020
11:56 AM | Audentes Therapeutics (Filer)
| Form POSASR
| |
01/15/2020
11:51 AM | Audentes Therapeutics (Filer)
| Form POS AM
| |
01/15/2020
11:49 AM | Audentes Therapeutics (Filer)
| Form POS AM
| |
01/15/2020
11:38 AM | Audentes Therapeutics (Filer)
| Form S-8 POS
| |
01/15/2020
11:37 AM | Audentes Therapeutics (Filer)
| Form S-8 POS
| |
01/15/2020
11:36 AM | Audentes Therapeutics (Filer)
| Form S-8 POS
| |
01/15/2020
11:34 AM | Audentes Therapeutics (Filer)
| Form S-8 POS
| |
01/15/2020
9:59 AM | Audentes Therapeutics (Subject)
The Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE
| |
01/15/2020
9:03 AM | Audentes Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/15/2020
5:12 AM | Audentes Therapeutics (Subject)
| Form SC 14D9/A
| |
01/15/2020
5:10 AM | Astellas Pharma Inc. (Filed by)
Audentes Therapeutics (Subject)
| Form SC TO-T/A
| |
01/10/2020
5:19 PM | Audentes Therapeutics (Issuer)
Soloway Thomas P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2020
5:18 PM | Audentes Therapeutics (Issuer)
Patterson Matthew R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2020
4:08 PM | Audentes Therapeutics (Subject)
| Form SC 14D9/A
| |
01/07/2020
4:03 PM | Astellas Pharma Inc. (Filed by)
Audentes Therapeutics (Subject)
| Form SC TO-T/A
| |
01/07/2020
9:17 AM | Audentes Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A
| |
12/27/2019
7:23 PM | Audentes Therapeutics (Subject)
| Form SC 14D9/A
| |
12/27/2019
6:25 PM | Astellas Pharma Inc. (Filed by)
Audentes Therapeutics (Subject)
| Form SC TO-T/A
| |
12/27/2019
3:10 PM | Audentes Therapeutics (Issuer)
LANGE LOUIS G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2019
5:05 PM | Audentes Therapeutics (Issuer)
Soloway Thomas P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2019
5:04 PM | Audentes Therapeutics (Issuer)
Mosbrooker Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2019
5:04 PM | Audentes Therapeutics (Issuer)
Meltz Mark A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2019
5:03 PM | Audentes Therapeutics (Issuer)
Holles Natalie C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2019
5:02 PM | Audentes Therapeutics (Issuer)
Conner Edward R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2019
5:51 AM | Audentes Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/16/2019
5:14 AM | Audentes Therapeutics (Subject)
| Form SC 14D9
| |
12/16/2019
5:10 AM | Astellas Pharma Inc. (Filed by)
Audentes Therapeutics (Subject)
| Form SC TO-T
| |
12/09/2019
4:17 PM | Audentes Therapeutics (Issuer)
Soloway Thomas P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2019
4:16 PM | Audentes Therapeutics (Issuer)
Patterson Matthew R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2019
4:15 PM | Audentes Therapeutics (Issuer)
Holles Natalie C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2019
3:01 PM | Astellas Pharma Inc. (Filed by)
Audentes Therapeutics (Subject)
| Form SC TO-C
| |
12/04/2019
3:04 PM | Astellas Pharma Inc. (Filed by)
Audentes Therapeutics (Subject)
| Form SC TO-C
| |
12/02/2019
8:53 PM | Audentes Therapeutics (Subject)
| Form SC14D9C
| |
12/02/2019
8:38 PM | Astellas Pharma Inc. (Filed by)
Audentes Therapeutics (Subject)
| Form SC TO-C
| |
11/12/2019
4:32 PM | Audentes Therapeutics (Issuer)
Patterson Matthew R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2019
11:11 AM | Audentes Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A
| |
11/07/2019
4:16 PM | Audentes Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2019
3:06 PM | Audentes Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/08/2019
8:54 PM | Audentes Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2019
5:11 PM | Audentes Therapeutics (Issuer)
LANGE LOUIS G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2019
3:17 PM | Audentes Therapeutics (Subject)
GREAT POINT PARTNERS LLC (Filed by)
| Form SC 13G
| |
09/09/2019
3:06 PM | Audentes Therapeutics (Issuer)
Soloway Thomas P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2019
3:05 PM | Audentes Therapeutics (Issuer)
Patterson Matthew R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2019
3:04 PM | Audentes Therapeutics (Issuer)
Holles Natalie C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2019
3:02 PM | Audentes Therapeutics (Filer)
| Form 8-K/A
| |
08/14/2019
6:03 PM | Audentes Therapeutics (Issuer)
Patterson Matthew R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2019
7:43 PM | Audentes Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/06/2019
3:06 PM | Audentes Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2019
3:26 PM | Audentes Therapeutics (Issuer)
Conner Edward R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2019
3:24 PM | Audentes Therapeutics (Issuer)
Conner Edward R. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/26/2019
3:07 PM | Audentes Therapeutics (Issuer)
LANGE LOUIS G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2019
3:42 PM | Audentes Therapeutics (Issuer)
PRASAD SUYASH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2019
3:41 PM | Audentes Therapeutics (Issuer)
Patterson Matthew R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2019
3:41 PM | Audentes Therapeutics (Issuer)
Holles Natalie C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2019
3:40 PM | Audentes Therapeutics (Issuer)
Soloway Thomas P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2019
3:30 PM | Audentes Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2019
3:02 PM | Audentes Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2019
3:42 PM | Audentes Therapeutics (Issuer)
PRASAD SUYASH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2019
8:30 PM | Audentes Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2019
3:03 PM | Audentes Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2019
1:15 PM | Audentes Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2019
3:30 PM | Audentes Therapeutics (Filer)
| Form DEFA14A
| |
04/26/2019
3:30 PM | Audentes Therapeutics (Filer)
| Form DEF 14A
| |
04/08/2019
6:11 AM | Audentes Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2019
4:54 PM | Audentes Therapeutics (Issuer)
Meltz Mark A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2019
4:53 PM | Audentes Therapeutics (Issuer)
Meltz Mark A (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/27/2019
4:03 PM | Audentes Therapeutics (Issuer)
LANGE LOUIS G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2019
4:16 PM | Audentes Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2019
3:32 PM | Audentes Therapeutics (Issuer)
PRASAD SUYASH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2019
3:31 PM | Audentes Therapeutics (Issuer)
Patterson Matthew R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2019
4:22 PM | Audentes Therapeutics (Subject)
Partner Fund Management, L.P. (Filed by)
| Form SC 13G/A
| |
02/14/2019
12:51 PM | Audentes Therapeutics (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
| Form SC 13G/A
| |
02/12/2019
8:42 AM | Audentes Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A
| |
02/08/2019
4:50 PM | Audentes Therapeutics (Issuer)
Patterson Matthew R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2019
4:29 PM | Audentes Therapeutics (Issuer)
Soloway Thomas P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2019
4:28 PM | Audentes Therapeutics (Issuer)
Smith Julie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2019
4:27 PM | Audentes Therapeutics (Issuer)
Schuetz Thomas J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2019
4:25 PM | Audentes Therapeutics (Issuer)
PRASAD SUYASH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2019
4:23 PM | Audentes Therapeutics (Issuer)
Morrison Scott W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2019
4:22 PM | Audentes Therapeutics (Issuer)
LANGE LOUIS G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2019
4:21 PM | Audentes Therapeutics (Issuer)
Jarrett Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2019
4:20 PM | Audentes Therapeutics (Issuer)
Holles Natalie C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2019
4:20 PM | Audentes Therapeutics (Issuer)
Goldberg Mark Alan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2019
6:28 PM | Audentes Therapeutics (Issuer)
Holles Natalie C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
